Value through Innovation17 January 2013

Your search results.

  1. idf_qrposter_yoon.pdf

    Joint 9th International Diabetes Federation Western Pacific Region (IDF-WPR) Congress and 4th Scientific Meeting of the Asian Association for the Study of Diabetes (AASD), 24-27 November 2012, Kyoto, Japan Yoon KH, Chuang LM, Pfarr E, Hach T, Gong Y, Broedl UC Phase II (1245.

    • Size: 43 kB
    • Last Update: 29.10.2012
  2. wcpd_qrcode_woerle.pdf

    7th World Congress on the Prevention of Diabetes and its Complications (WCPD), 11-14 November 2012, Madrid, Spain Woerle HJ, Ferrannini E, Berk A, Manun’Ebo M, Pinnetti S, Broedl UC Phase II (1245.24; encore of ADA 2012) Safety and efficacy of empagliflozin as monotherapy or add-on to metformin in

    • Size: 43 kB
    • Last Update: 29.10.2012
  3. Employee

    • Size: 16 kB
    • Last Update: 29.10.2012
  4. Employee HR

    • Size: 20 kB
    • Last Update: 29.10.2012
  5. Homepage

    • Size: 1 kB
    • Last Update: 22.11.2012
  6. Employee

    • Size: 111 kB
    • Last Update: 29.10.2012
  7. 14 November 2012 World Diabetes Day

    Boehringer Ingelheim provided €15,000 in financial support for the International Diabetes Federation (IDF) step-by-step, as employees run to support World Diabetes Day (WDD)

    • Size: 10 kB
    • Last Update: 14.11.2012
  8. Employee Animal Health

    • Size: 810 kB
    • Last Update: 29.10.2012
  9. News Topics

    Corporate Topics Corporate News & Information Corporate News & Information Research & Development R&D News & Information R&D News & Information Acute Ischaemic Stroke Stroke News & Information Stroke News & Information Cancer Cancer News & Information Cancer News & Information Cardiovascular

    • Size: 17 kB
    • Last Update: 8.11.2012
  10. 26 January 2012 Oncology

    Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*

    • Size: 15 kB
    • Last Update: 5.11.2012